This study is the first to systematically explore and reveal the mechanistic link between TPM1 mutations and RCM pathogenesis (particularly via the CaMKII/HDAC4 axis), offering new insights into the genetic etiology of RCM and identifying potential therapeutic targets. Here, HDAC4 is linked to cardiomyopathy, familial restrictive, 1.